Anti-AMELY/ AMGL/ AMGY functional antibody

Anti-AMELY/ AMGL/ AMGY functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to AMELY/AMELY products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0659-Ab-1/ GM-Tg-hg-SE0659-Ab-2Anti-Human AMELY monoclonal antibodyHuman
GM-Tg-rg-SE0659-Ab-1/ GM-Tg-rg-SE0659-Ab-2Anti-Rat AMELY monoclonal antibodyRat
GM-Tg-mg-SE0659-Ab-1/ GM-Tg-mg-SE0659-Ab-2Anti-Mouse AMELY monoclonal antibodyMouse
GM-Tg-cynog-SE0659-Ab-1/ GM-Tg-cynog-SE0659-Ab-2Anti-Cynomolgus/ Rhesus macaque AMELY monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0659-Ab-1/ GM-Tg-felg-SE0659-Ab-2Anti-Feline AMELY monoclonal antibodyFeline
GM-Tg-cang-SE0659-Ab-1/ GM-Tg-cang-SE0659-Ab-2Anti-Canine AMELY monoclonal antibodyCanine
GM-Tg-bovg-SE0659-Ab-1/ GM-Tg-bovg-SE0659-Ab-2Anti-Bovine AMELY monoclonal antibodyBovine
GM-Tg-equg-SE0659-Ab-1/ GM-Tg-equg-SE0659-Ab-2Anti-Equine AMELY monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0659-Ab-1/ GM-Tg-hg-SE0659-Ab-2; GM-Tg-rg-SE0659-Ab-1/ GM-Tg-rg-SE0659-Ab-2;
GM-Tg-mg-SE0659-Ab-1/ GM-Tg-mg-SE0659-Ab-2; GM-Tg-cynog-SE0659-Ab-1/ GM-Tg-cynog-SE0659-Ab-2;
GM-Tg-felg-SE0659-Ab-1/ GM-Tg-felg-SE0659-Ab-2; GM-Tg-cang-SE0659-Ab-1/ GM-Tg-cang-SE0659-Ab-2;
GM-Tg-bovg-SE0659-Ab-1/ GM-Tg-bovg-SE0659-Ab-2; GM-Tg-equg-SE0659-Ab-1/ GM-Tg-equg-SE0659-Ab-2
Products NameAnti-AMELY monoclonal antibody
Formatmab
Target NameAMELY
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AMELY benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0659-Ag-1Recombinant multi-species AMELY/ AMGL/ AMGY protein
    ORF Viral VectorpGMLP004757human AMELY Lentivirus plasmid
    ORF Viral VectorvGMLP004757human AMELY Lentivirus particle


    Target information

    Target IDGM-SE0659
    Target NameAMELY
    Gene ID266
    Gene Symbol and SynonymsAMELY,AMGL,AMGY
    Uniprot AccessionQ99218
    Uniprot Entry NameAMELY_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000099721
    Target ClassificationN/A

    The target: AMELY, gene name: AMELY, also named as AMGL, AMGY. This gene encodes a member of the amelogenin family of extracellular matrix proteins. Amelogenins are involved in biomineralization during tooth enamel development. Mutations in a related gene on chromosome X cause X-linked amelogenesis imperfecta. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.